Esterase‐Labile Quaternium Lipidoid Enabling Improved mRNA‐LNP Stability and Spleen‐Selective mRNA Transfection
Advanced Materials · 2023-11 · 35 (46)
DOI: 10.1002/adma.202303614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 15.10.2023. Verfasst von Runnan Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University,…. Hauptthemen laut MEDLINE: Esterases, Nanoparticles. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.
Abstract (Originalsprache)
Ionizable cationic lipids are recognized as an essential component of lipid nanoparticles (LNPs) for messenger RNA (mRNA) delivery but can be confounded by low lipoplex stability with mRNA during storage and in vivo delivery. Herein, the rational design and combinatorial synthesis of esterase‐triggered decationizable quaternium lipid‐like molecules (lipidoids) are reported to develop new LNPs with high delivery efficiency and improved storage stability. This top lipidoid carries positive charges at the physiological condition but promptly acquires negative charges in the presence of esterase, thus permitting stable mRNA encapsulation during storage and in vivo delivery while balancing efficient mRNA release in the cytosol. An optimal LNP formulation is then identified through orthogonal optimization, which enables efficacious mRNA transfection selectively in the spleen following intravenous administration. LNP‐mediated delivery of ovalbumin (OVA)‐encoding mRNA induces efficient antigen expression in antigen‐presenting cells and elicits robust antigen‐specific immune responses against OVA‐transduced tumors. The work demonstrates the potential of decationizable quaternium lipidoids for spleen‐selective RNA transfection and cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, China.
- Key Laboratory of Biomass Chemical Engineering of the Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, China.
- ZJU-Hangzhou Global Scientific and Technological Innovation Center, 311215, Hangzhou, China.
- The Center for Integrated Oncology and Precision Medicine of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
- Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, 310006, China.
- Zhejiang Longcharm Bio-tech Pharma Co., Ltd., Hangzhou, 310018, China.
ORCID-Profile: Youqing Shen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Key Research and Development Program of Zhejiang Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhang, R., Shao, S., Piao, Y., Xiang, J., Wei, X., Zhang, Z., Zhou, Z., Tang, J., Qiu, N., Xu, X., Liu, Y., & Shen, Y. (2023). Esterase‐Labile Quaternium Lipidoid Enabling Improved mRNA‐LNP Stability and Spleen‐Selective mRNA Transfection. Advanced Materials, 35(46). https://doi.org/10.1002/adma.202303614
Vancouver
Zhang R, Shao S, Piao Y, Xiang J, Wei X, Zhang Z, et al. Esterase‐Labile Quaternium Lipidoid Enabling Improved mRNA‐LNP Stability and Spleen‐Selective mRNA Transfection. Advanced Materials. 2023;35(46). doi:10.1002/adma.202303614
BibTeX
@article{Zhang2023,
author = {Zhang, Runnan and Shao, Shiqun and Piao, Ying and Xiang, Jiajia and Wei, Xuyong and Zhang, Zhen and Zhou, Zhuxian and Tang, Jianbin and Qiu, Nasha and Xu, Xiao and Liu, Yanpeng and Shen, Youqing},
title = {Esterase‐Labile Quaternium Lipidoid Enabling Improved mRNA‐LNP Stability and Spleen‐Selective mRNA Transfection},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {46},
doi = {10.1002/adma.202303614}
}
EUVIMED